يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Stein, Mark N"', وقت الاستعلام: 0.86s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249).

    المؤلفون: Synold, Timothy W, Plets, Melissa, Tangen, Catherine M, Heath, Elisabeth I, Palapattu, Ganesh S, Mack, Philip C, Stein, Mark N, Meng, Maxwell V, Lara, Primo, Vogelzang, Nicholas J, Thompson, Ian Murchie, Ryan, Christopher W

    المصدر: Kidney cancer (Clifton, Va.). 3(2)

    مصطلحات موضوعية: Renal cell carcinoma, adjuvant chemotherapy, everolimus, pharmacokinetics, therapeutic drug monitoring

    وصف الملف: application/pdf

    الوصول الحر: https://escholarship.org/uc/item/8tz1x6f2Test

    View record in eScholarship

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial.

    المؤلفون: Lara, Primo N, Tangen, Catherine, Heath, Elisabeth I, Gulati, Shuchi, Stein, Mark N, Meng, Maxwell, Alva, Ajjai Shivaram, Pal, Sumanta K, Puzanov, Igor, Clark, Joseph I, Choueiri, Toni K, Agarwal, Neeraj, Uzzo, Robert, Haas, Naomi B, Synold, Timothy W, Plets, Melissa, Vaishampayan, Ulka N, Shuch, Brian M, Lerner, Seth, Thompson, Ian M, Ryan, Christopher W

    المصدر: Eur Urol ; ISSN:1873-7560

    مصطلحات موضوعية: Adjuvant, Everolimus, High risk, Kidney cancer

    العلاقة: https://doi.org/10.1016/j.eururo.2024.05.012Test; https://pubmed.ncbi.nlm.nih.gov/38811313Test

    الإتاحة: https://doi.org/10.1016/j.eururo.2024.05.012Test
    https://pubmed.ncbi.nlm.nih.gov/38811313Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.

    المؤلفون: Ryan, Christopher W1 (AUTHOR) ryanc@ohsu.edu, Tangen, Catherine M2 (AUTHOR), Heath, Elisabeth I3 (AUTHOR), Stein, Mark N4 (AUTHOR), Meng, Maxwell V5 (AUTHOR), Alva, Ajjai S6 (AUTHOR), Pal, Sumanta K7 (AUTHOR), Puzanov, Igor8 (AUTHOR), Clark, Joseph I9 (AUTHOR), Choueiri, Toni K10 (AUTHOR), Agarwal, Neeraj11 (AUTHOR), Uzzo, Robert G12 (AUTHOR), Haas, Naomi B13 (AUTHOR), Synold, Timothy W7 (AUTHOR), Plets, Melissa2 (AUTHOR), Vaishampayan, Ulka N6 (AUTHOR), Shuch, Brian M14 (AUTHOR), Thompson, Ian M15 (AUTHOR), Lara, Primo N16 (AUTHOR)

    المصدر: Lancet. Sep2023, Vol. 402 Issue 10407, p1043-1051. 9p.

    مصطلحات موضوعية: *RENAL cell carcinoma, *CLINICAL trials, *NEPHRECTOMY, *EVEROLIMUS, *WEB-based user interfaces, *COMMUNITY centers

    الشركة/الكيان: NATIONAL Cancer Institute (U.S.) , NATIONAL Institutes of Health (U.S.)


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث